GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Sinobioway Biomedicine Co Ltd (SZSE:002581) » Definitions » EV-to-FCF

Shandong Sinobioway Biomedicine Co (SZSE:002581) EV-to-FCF : -80.95 (As of Apr. 22, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Shandong Sinobioway Biomedicine Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Shandong Sinobioway Biomedicine Co's Enterprise Value is ¥5,287.2 Mil. Shandong Sinobioway Biomedicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-65.3 Mil. Therefore, Shandong Sinobioway Biomedicine Co's EV-to-FCF for today is -80.95.

The historical rank and industry rank for Shandong Sinobioway Biomedicine Co's EV-to-FCF or its related term are showing as below:

SZSE:002581' s EV-to-FCF Range Over the Past 10 Years
Min: -1257.02   Med: -48.66   Max: 899.84
Current: -79.84

During the past 13 years, the highest EV-to-FCF of Shandong Sinobioway Biomedicine Co was 899.84. The lowest was -1257.02. And the median was -48.66.

SZSE:002581's EV-to-FCF is ranked worse than
100% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.31 vs SZSE:002581: -79.84

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-22), Shandong Sinobioway Biomedicine Co's stock price is ¥8.45. Shandong Sinobioway Biomedicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-0.527. Therefore, Shandong Sinobioway Biomedicine Co's PE Ratio (TTM) for today is At Loss.


Shandong Sinobioway Biomedicine Co EV-to-FCF Historical Data

The historical data trend for Shandong Sinobioway Biomedicine Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sinobioway Biomedicine Co EV-to-FCF Chart

Shandong Sinobioway Biomedicine Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 377.05 -244.41 -132.47 -121.79 -235.15

Shandong Sinobioway Biomedicine Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -263.31 -235.15 753.63 -1,231.92 -104.29

Competitive Comparison of Shandong Sinobioway Biomedicine Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Shandong Sinobioway Biomedicine Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shandong Sinobioway Biomedicine Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shandong Sinobioway Biomedicine Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Shandong Sinobioway Biomedicine Co's EV-to-FCF falls into.


;
;

Shandong Sinobioway Biomedicine Co EV-to-FCF Calculation

Shandong Sinobioway Biomedicine Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=5287.152/-65.312
=-80.95

Shandong Sinobioway Biomedicine Co's current Enterprise Value is ¥5,287.2 Mil.
Shandong Sinobioway Biomedicine Co's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-65.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shandong Sinobioway Biomedicine Co  (SZSE:002581) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Shandong Sinobioway Biomedicine Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8.45/-0.527
=At Loss

Shandong Sinobioway Biomedicine Co's share price for today is ¥8.45.
Shandong Sinobioway Biomedicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.527.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Shandong Sinobioway Biomedicine Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Shandong Sinobioway Biomedicine Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Shandong Sinobioway Biomedicine Co Business Description

Traded in Other Exchanges
N/A
Address
No.18, Chaoyang Road, Zhangdian District, Zibo City, Shandong, CHN, 255068
Shandong Sinobioway Biomedicine Co Ltd is engaged in the research, development, manufacturing and marketing of trimethyl orthoformate and triethyl orthoformate.
Executives
He Xun Executives
Yang Xiao Min Director
Yu Tong Jie Executives
Yan Li Director

Shandong Sinobioway Biomedicine Co Headlines

No Headlines